Key result
Female AF patients match males as high-cost healthcare users, accounting for ~32% of both groups.
Why the study?
Healthcare resource use for AF is high and may not be equivalent across all patients, motivating an examination of whether sex differences exist among high-cost users.
Are there sex differences in healthcare utilization and costs among high-cost users with atrial fibrillation?
Cohort (n=48,030)
Are there sex differences in healthcare utilization and costs among high-cost users with atrial fibrillation?
Absolute Event Rate: 31.9% vs 31.7%
Female patients with atrial fibrillation represent an equal proportion of high-cost users and account for nearly half of total costs despite a lower overall prevalence of AF, highlighting a need for targeted interventions.
Equal female representation among high-cost AF users despite lower prevalence may guide equitable resource planning; leaves open sex-specific drivers and intervention targets.
BackgroundHealthcare resource use for atrial fibrillation (AF) is high, but it may not be equivalent across all patients. We examined whether sex differences exist for AF high-cost users (HCUs), who account for the top 10% of total acute care costs.MethodsAll patients aged ≥ 20 years who presented to the emergency department (ED) or were hospitalized with AF were identified in Alberta, Canada, between 2011 and 2015. The cohort was categorized by sex into HCUs and non-HCUs. Healthcare utilization was defined as ED, hospital, and physician visits, and costs included those for hospitalization, ambulatory care, physician billing, and drugs. All costs were inflated to 2022 Canadian dollars (CAD$).ResultsAmong 48,030 AF patients, 45.1% were female. Of these, 31.8% were HCUs, and the proportions of female and male patients were equal (31.9% vs 31.7%). Female HCUs were older, more likely to have hypertension and heart failure, and had a higher stroke risk than male HCUs. Mean healthcare utilization did not differ among HCUs by sex, except for number of ED visits, which was higher in male patients (12.7% vs 9.2%, P < 0.0001). Overall, HCUs accounted for 65.8% of the total costs (CAD$3.4 billion). Almost half of total HCU costs were attributable to female HCUs (CAD$966.1 million). Significant differences were present in the distributions of HCU-related costs (male patients: 74.6% hospitalization, 9.5% ambulatory care, 12.4% physician billing, 3.5% drugs; female patients: 77.7% hospitalization, 7.4% ambulatory care, 11.5% physician billing, 3.5% drugs, P < 0.0001).ConclusionsDespite having a lower AF prevalence, female patients represent an equal proportion of HCUs, and account for almost half the total HCU costs. Interventions targeted at reducing the number of AF HCU are needed, particularly for female patients.
No takes yet. Share an insight, caveat, or question.
Sandhu et al. (2023) conducted a cohort in Atrial fibrillation (n=48,030). Female sex vs. Male sex was evaluated on Proportion of patients qualifying as high-cost users (HCUs). Despite comprising a lower overall proportion of atrial fibrillation cases, female patients represented an equal proportion of high-cost users compared to males (31.9% vs 31.7%) and accounted for nearly half of total high-cost user costs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: